Kognole background as a computational chemist and a biophysicist to fuel product development and client services for SilcsBio June 8, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of Abhishek Kognole, PhD, a computational chemist and a biophysicist, as Applications [...]

Dr. MacKerell to be honored at the ACS Spring 2022 National Meeting, March 20-24, in San Diego March 10, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, announced today its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., PhD, has been awarded the [...]

Tech on Deck to feature fresh content by Early Charm’s expert team of scientists and entrepreneurs on unmet market needs and challenges March 7, 2022, Baltimore, MD – Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today announced the launch of its Tech on Deck blog. Early Charm’s [...]

FOR IMMEDIATE RELEASE:   SilcsBio Spinout Raises $1.5 Million to Advance Drug Development New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research   December 2, 2021, Baltimore, MD – Rasio Therapeutics, a joint venture formed by SilcsBio and the National Foundation for Cancer Research (NFCR) to develop [...]

Song will focus on web applications development and solutions to help drive SilcsBio’s continued growth September 28, 2021, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of KC Song as Full Stack Developer. Song joins the SilcsBio team as an experienced [...]